| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways | Kongpetch, S. Senggunprai, L. Prawan, A. Kukongviriyapan, U. Kukongviriyapan, V. |
2020 | ||||
| 2. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways | Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Jusakul, A Laphanuwat, P Kongpetch, S |
2022 | ||||
| 3. | FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells. | Oeurn, K Jusakul, A Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Kongpetch, S |
2023 | ||||
| 4. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 | ||||
| 5. | Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway. | Jaidee, R Pocasap, P Jusakul, A Senggunprai, L Prawan, A Hong, JH Heng, HL Kukongviriyapan, V Teh, BT Kongpetch, S |
2025 | Count | 2 | 5 | 1 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways | Kongpetch, S. Senggunprai, L. Prawan, A. Kukongviriyapan, U. Kukongviriyapan, V. |
2020 |
Naunyn-Schmiedeberg's Archives of Pharmacology 9 (393), pp. 1681-1690 |
||||||||
| 2. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways | Jaidee, R. Kukongviriyapan, V. Senggunprai, L. Prawan, A. Jusakul, A. Laphanuwat, P. Kongpetch, S. |
2022 |
Life Sciences (296), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways. | Jaidee, R Kongpetch, S Senggunprai, L Prawan, A Kukongviriyapan, U Kukongviriyapan, V |
2020 |
Naunyn-Schmiedeberg's archives of pharmacology 9 (393), pp. 1681-1690 |
|
| 2. | Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. | Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Jusakul, A Laphanuwat, P Kongpetch, S |
2022 |
Life sciences (), pp. 120427 |
|
| 3. | FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells. | Oeurn, K Jusakul, A Jaidee, R Kukongviriyapan, V Senggunprai, L Prawan, A Kongpetch, S |
2023 |
In vivo (Athens, Greece) 4 (37), pp. 1628-1637 |
|
| 4. | Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway. | Jaidee, R Pocasap, P Jusakul, A Senggunprai, L Prawan, A Hong, JH Heng, HL Kukongviriyapan, V Teh, BT Kongpetch, S |
2025 |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (189), pp. 118273 |
|
| 5. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 |
Scientific reports 1 (15), pp. 8621 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways | Rattanaporn Jaidee Sarinya Kongpetch Laddawan Senggunprai Auemduan Prawan Upa Kukongviriyapan Veerapol Kukongviriyapan |
2020 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 9.0 (393.0), pp. 1681.0-1690.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|